AAA Ascension eyes up Ivantis

Ascension eyes up Ivantis

Ivantis, a US-based  eye disease company has raised $27m in its series B round from a consortium led by corporate venturing unit Ascension Health Ventures as a new investor.

Venture capital firms New Enterprise Associates (NEA) and Delphi Ventures, and MemorialCare Innovation Fund also participated in the round.

In June 2011, Ivantis raised $17m from NEA and Delphi, having been incubated at NEA in 2007.

Leave a comment

Your email address will not be published. Required fields are marked *